Vault-13

ERNEXA THERAPEUTICS INC

COM · CUSIP 114082308

0 institutional holders -20 vs Q1 2026
—reported value*
0 new 0 added 0 reduced 19 sold out net sold ≈ $589.5k (-3.0m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

01020Q2 25: 13Q3 25: 14Q4 25: 14Q1 26: 20Q2 26: 00Q2 25Q3 25Q4 25Q1 26Q2 26
Numbers
QuarterHolders
Q2 202513
Q3 202514
Q4 202514
Q1 202620
Q2 20260

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q3 25: 6 bought or addedQ3 25: 2 cut or sold outQ3 25Q4 25: 7 bought or addedQ4 25: 4 cut or sold outQ4 25Q1 26: 10 bought or addedQ1 26: 5 cut or sold outQ1 26Q2 26: 0 bought or addedQ2 26: 19 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q3 202562
Q4 202574
Q1 2026105
Q2 2026019

Biggest buyers

None

Biggest sellers

Bleichroeder LP Sold out -2,000,000-2.0m
Corient Private Wealth LP Sold out -438,093-438.1k
GEODE CAPITAL MANAGEMENT, LLC Sold out -244,446-244.4k
XTX Topco Ltd Sold out -54,338-54.3k
Warberg Asset Management LLC Sold out -50,000-50.0k
JANE STREET GROUP, LLC Sold out -41,167-41.2k
CITADEL ADVISORS LLC Sold out -33,076-33.1k
VANGUARD CAPITAL MANAGEMENT LLC Sold out -26,504-26.5k
VANGUARD FIDUCIARY TRUST CO Sold out -25,447-25.4k
UBS Group AG Sold out -21,233-21.2k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Cherington Charles 13D · may seek influence filed 2026-02-17
Stated purposeItem 4 is hereby amended by adding the following: The Reporting Person acquired 4,000,000 shares of the Issuer's Common Stock and 4,000,000 Warrants in the Offering. The Reporting Person has no present plan or proposal that relates to, or could result in, any of the events referred to in paragraphs (a) through (j) inclusive, of Item 4 of Schedule 13D. Full filing
 34.7% 10.8m 2026-02-17
Freebird Partners LP 13G · passive investor filed 2025-12-19 9.9% 786.0k 2025-12-19
Konar Shameek 13G · passive investor filed 2025-12-16 7.1% 558.5k 2025-12-16
Bleichroeder LP 13G · institution new · filed 2026-05-14 6.9% new 80.0k 2026-05-14

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change